Cargando…

Select-agent status could slow development of anti-SARS therapies

Detalles Bibliográficos
Autor principal: Matthews, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096004/
https://www.ncbi.nlm.nih.gov/pubmed/23223045
http://dx.doi.org/10.1038/nm1212-1722
_version_ 1783510731286642688
author Matthews, Susan
author_facet Matthews, Susan
author_sort Matthews, Susan
collection PubMed
description
format Online
Article
Text
id pubmed-7096004
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-70960042020-03-26 Select-agent status could slow development of anti-SARS therapies Matthews, Susan Nat Med Article Nature Publishing Group US 2012-12-06 2012 /pmc/articles/PMC7096004/ /pubmed/23223045 http://dx.doi.org/10.1038/nm1212-1722 Text en © Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2012 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Matthews, Susan
Select-agent status could slow development of anti-SARS therapies
title Select-agent status could slow development of anti-SARS therapies
title_full Select-agent status could slow development of anti-SARS therapies
title_fullStr Select-agent status could slow development of anti-SARS therapies
title_full_unstemmed Select-agent status could slow development of anti-SARS therapies
title_short Select-agent status could slow development of anti-SARS therapies
title_sort select-agent status could slow development of anti-sars therapies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096004/
https://www.ncbi.nlm.nih.gov/pubmed/23223045
http://dx.doi.org/10.1038/nm1212-1722
work_keys_str_mv AT matthewssusan selectagentstatuscouldslowdevelopmentofantisarstherapies